Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Division of Medical Ethics, NYU Grossman School of Medicine, New York, NY, United States of America.
PLoS One. 2023 Jan 20;18(1):e0280542. doi: 10.1371/journal.pone.0280542. eCollection 2023.
The growing amount of data produced through digital technologies holds great promise for advancing behavioral research. Scholars worldwide now have the chance to access an incredible amount of personal information, thanks to the digital trace users continuously leave behind them. Private corporations play a crucial role in this scenario as the leading collectors of data on users, thus creating new incentives for partnerships between academic institutions and private companies. Due to the concerns that academic-company partnerships might raise and the ethical issues connected with Big Data research, our study explores the challenges and opportunities associated with the academic use of corporate data. We conducted 39 semi-structured interviews with academic scholars (professors, senior researchers, and postdocs) involved in Big Data research in Switzerland and the United States. We also investigated their opinions on using corporate data for scholarly research. Researchers generally showed an interest in using corporate data; however, they coincidentally shared ethical reservations towards this practice, such as threats to research integrity and concerns about a lack of transparency of companies' practices. Furthermore, participants mentioned issues of scholarly access to corporate data that might both disadvantage the academic research community and create issues of scientific validity. Academic-company partnerships could be a positive development for the advancement of scholarly behavioral research. However, strategies should be implemented to appropriately guide collaborations and appropriate use of corporate data, like implementing updated protocols and tools to govern conflicts of interest and the institution of transparent regulatory bodies to ensure adequate oversight of academic-corporate research collaborations.
数字技术产生的大量数据为推进行为研究带来了巨大的希望。由于用户不断留下的数字痕迹,全球学者现在有机会访问大量的个人信息。私营公司在这种情况下起着至关重要的作用,因为它们是用户数据的主要收集者,从而为学术机构和私营公司之间的合作创造了新的激励。由于学术-公司伙伴关系可能引发的关注以及与大数据研究相关的道德问题,我们的研究探讨了学术使用公司数据所带来的挑战和机遇。我们对参与瑞士和美国大数据研究的 39 名学术学者(教授、高级研究人员和博士后)进行了半结构化访谈,并调查了他们对使用公司数据进行学术研究的看法。学者们普遍对使用公司数据表现出了兴趣;然而,他们碰巧对这种做法存在道德保留意见,例如对研究完整性的威胁以及对公司做法缺乏透明度的担忧。此外,参与者还提到了学术获取公司数据的问题,这些问题可能既不利于学术研究界,也可能对科学有效性产生问题。学术-公司伙伴关系可能是推进学术行为研究的积极发展。然而,应该实施策略来适当指导合作和公司数据的适当使用,例如实施更新的协议和工具来管理利益冲突,并建立透明的监管机构,以确保对学术-公司研究合作进行充分监督。